Thomas K Slack, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 126 Eastwind Cir, Wellfleet, MA 02667 Phone: 508-349-0948 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it will be issued U.S. Patent Numbers 7,795,025 and 7,794,704 on Tuesday, September 14th, which continue to extend the company's patent portfolio covering its retinal pigment epithelial (RPE) cell programs.
Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.
According to the Assisted Living Federation of America, "the bar for what constitutes excellence in senior living has just been raised."
Pancreatic cancer, the fourth leading cause of cancer death in the United States, is often diagnosed at a late stage, when curative treatment is no longer possible. A team led by investigators at Beth Israel Deaconess Medical Center has now identified and validated an accurate 5-gene classifier for discriminating early pancreatic cancer from non-malignant tissue.
The first MRI scan to show 'brown fat' in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity.
› Verified 2 days ago